Literature DB >> 1548778

Autopresentation of hepatitis B virus envelope antigens by T cells.

C Ferrari1, M Pilli, A Penna, A Bertoletti, A Valli, A Cavalli, G Pasetti, F Fiaccadori.   

Abstract

Processing and presentation by T cells appear to be limited to antigens that can directly interact with the T-cell surface, thereby overcoming the T-cell inefficiency in antigen capture and internalization. Our study provides evidence that the hepatitis B virus (HBV) envelope proteins can also be efficiently processed and presented by CD4+ and CD8+ T cells to other T cells in a human leukocyte antigen class II-restricted fashion. This phenomenon suggests a receptor-mediated interaction between T cells and the HBV envelope and defines a system that can, we hope, be exploited for the identification of the receptor binding site within the HBV envelope and for the characterization of the putative cellular HBV receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548778      PMCID: PMC289054     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Is suppression a function of class II--restricted cytotoxic T cells?

Authors:  A Lanzavecchia
Journal:  Immunol Today       Date:  1989-05

2.  Human TH1 and TH2 subsets: doubt no more.

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1991-08

3.  Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity.

Authors:  D R Milich; D L Peterson; G G Leroux-Roels; R A Lerner; F V Chisari
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

4.  T cells can present antigens such as HIV gp120 targeted to their own surface molecules.

Authors:  A Lanzavecchia; E Roosnek; T Gregory; P Berman; S Abrignani
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

5.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

6.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

7.  Demonstration of a firm association between hepatitis B surface antigen proteins bearing polymerized human albumin binding sites and core-specific determinants in serum hepatitis B viral particles.

Authors:  M A Petit; F Capel; J Pillot
Journal:  Mol Immunol       Date:  1985-11       Impact factor: 4.407

8.  Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B.

Authors:  C Ferrari; A Penna; P Sansoni; T Giuberti; T M Neri; F V Chisari; F Fiaccadori
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

9.  Hepadnavirus infection of peripheral blood lymphocytes in vivo: woodchuck and chimpanzee models of viral hepatitis.

Authors:  B E Korba; F Wells; B C Tennant; G H Yoakum; R H Purcell; J L Gerin
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

10.  Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity.

Authors:  G F Del Prete; M De Carli; M Ricci; S Romagnani
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  8 in total

1.  Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients.

Authors:  S Stoll-Becker; R Repp; D Glebe; S Schaefer; J Kreuder; M Kann; F Lampert; W H Gerlich
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Development of PCR-ELISA for the detection of hepatitis B virus x gene expression and clinical application.

Authors:  Jong-Wan Kim; Jung-Hyun Shim; Joo-Won Park; Won-Cheol Jang; H K Chang; Il Han Song; Sun-Young Baek; Seok-Ho Lee; Do-Young Yoon; Sue-Nie Park
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

3.  The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway.

Authors:  E Lara-Pezzi; A L Armesilla; P L Majano; J M Redondo; M López-Cabrera
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

Review 4.  Hepatitis B virus immunopathology.

Authors:  F V Chisari; C Ferrari
Journal:  Springer Semin Immunopathol       Date:  1995

5.  α-Mannosidase I Protein Expression in Peripheral Blood Mononuclear Cells Is Upregulated During Hepatitis B Virus Infection.

Authors:  Libin Jiang; Song Hu; Deying Tian; Xiaojing Zou; Man He
Journal:  Viral Immunol       Date:  2015-11-16       Impact factor: 2.257

6.  Activation of the HLA-DRA gene in primary human T lymphocytes: novel usage of TATA and the X and Y promoter elements.

Authors:  G K Matsushima; Y Itoh-Lindstrom; J P Ting
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

7.  Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice.

Authors:  Upendra K Kar; Janina Jiang; Cheryl I Champion; Sahar Salehi; Minu Srivastava; Sherven Sharma; Shahrooz Rabizadeh; Kayvan Niazi; Valerie Kickhoefer; Leonard H Rome; Kathleen A Kelly
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

8.  Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein.

Authors:  A R Neurath; N Strick; Y Y Li
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.